nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3B—coronary artery disease	0.633	1	CbGaD
Lithium—IMPA2—myocardium—coronary artery disease	0.00405	0.0832	CbGeAlD
Lithium—GSK3B—myocardium—coronary artery disease	0.00398	0.0817	CbGeAlD
Lithium—IMPA1—heart—coronary artery disease	0.00377	0.0774	CbGeAlD
Lithium—GSK3A—cardiac ventricle—coronary artery disease	0.00368	0.0755	CbGeAlD
Lithium—IMPA1—cardiovascular system—coronary artery disease	0.00356	0.0731	CbGeAlD
Lithium—GSK3A—myocardium—coronary artery disease	0.00346	0.071	CbGeAlD
Lithium—IMPA2—heart—coronary artery disease	0.00283	0.0581	CbGeAlD
Lithium—IMPA1—blood—coronary artery disease	0.00281	0.0578	CbGeAlD
Lithium—GSK3B—heart—coronary artery disease	0.00278	0.057	CbGeAlD
Lithium—GSK3B—cardiovascular system—coronary artery disease	0.00262	0.0538	CbGeAlD
Lithium—IMPA2—cardiac atrium—coronary artery disease	0.00242	0.0497	CbGeAlD
Lithium—GSK3A—heart—coronary artery disease	0.00241	0.0496	CbGeAlD
Lithium—GSK3A—cardiovascular system—coronary artery disease	0.00228	0.0468	CbGeAlD
Lithium—IMPA2—blood—coronary artery disease	0.00211	0.0434	CbGeAlD
Lithium—GSK3B—blood—coronary artery disease	0.00207	0.0425	CbGeAlD
Lithium—GSK3A—cardiac atrium—coronary artery disease	0.00206	0.0424	CbGeAlD
Lithium—GSK3A—blood—coronary artery disease	0.0018	0.037	CbGeAlD
Lithium—Gastrointestinal pain—Enalapril—coronary artery disease	9.7e-05	0.000671	CcSEcCtD
Lithium—Abdominal pain—Pravastatin—coronary artery disease	9.69e-05	0.000671	CcSEcCtD
Lithium—Body temperature increased—Pravastatin—coronary artery disease	9.69e-05	0.000671	CcSEcCtD
Lithium—Hypotension—Losartan—coronary artery disease	9.68e-05	0.00067	CcSEcCtD
Lithium—Dysgeusia—Lisinopril—coronary artery disease	9.67e-05	0.000669	CcSEcCtD
Lithium—Dizziness—Clopidogrel—coronary artery disease	9.65e-05	0.000668	CcSEcCtD
Lithium—Feeling abnormal—Telmisartan—coronary artery disease	9.64e-05	0.000667	CcSEcCtD
Lithium—Decreased appetite—Perindopril—coronary artery disease	9.6e-05	0.000664	CcSEcCtD
Lithium—Dizziness—Lovastatin—coronary artery disease	9.59e-05	0.000664	CcSEcCtD
Lithium—Loss of consciousness—Ramipril—coronary artery disease	9.57e-05	0.000662	CcSEcCtD
Lithium—Gastrointestinal pain—Telmisartan—coronary artery disease	9.57e-05	0.000662	CcSEcCtD
Lithium—Vertigo—Timolol—coronary artery disease	9.56e-05	0.000662	CcSEcCtD
Lithium—Somnolence—Furosemide—coronary artery disease	9.54e-05	0.000661	CcSEcCtD
Lithium—Syncope—Timolol—coronary artery disease	9.54e-05	0.00066	CcSEcCtD
Lithium—Diarrhoea—Eplerenone—coronary artery disease	9.52e-05	0.000659	CcSEcCtD
Lithium—Fatigue—Perindopril—coronary artery disease	9.52e-05	0.000659	CcSEcCtD
Lithium—Vomiting—Fenofibrate—coronary artery disease	9.44e-05	0.000653	CcSEcCtD
Lithium—Musculoskeletal discomfort—Losartan—coronary artery disease	9.44e-05	0.000653	CcSEcCtD
Lithium—Convulsion—Ramipril—coronary artery disease	9.43e-05	0.000653	CcSEcCtD
Lithium—Abdominal pain—Trandolapril—coronary artery disease	9.41e-05	0.000651	CcSEcCtD
Lithium—Body temperature increased—Trandolapril—coronary artery disease	9.41e-05	0.000651	CcSEcCtD
Lithium—Dizziness—Ezetimibe—coronary artery disease	9.4e-05	0.000651	CcSEcCtD
Lithium—Body temperature increased—Enalapril—coronary artery disease	9.38e-05	0.000649	CcSEcCtD
Lithium—Abdominal pain—Enalapril—coronary artery disease	9.38e-05	0.000649	CcSEcCtD
Lithium—Feeling abnormal—Captopril—coronary artery disease	9.37e-05	0.000649	CcSEcCtD
Lithium—Rash—Fenofibrate—coronary artery disease	9.36e-05	0.000648	CcSEcCtD
Lithium—Dermatitis—Fenofibrate—coronary artery disease	9.35e-05	0.000647	CcSEcCtD
Lithium—Loss of consciousness—Timolol—coronary artery disease	9.35e-05	0.000647	CcSEcCtD
Lithium—Decreased appetite—Furosemide—coronary artery disease	9.33e-05	0.000646	CcSEcCtD
Lithium—Headache—Fenofibrate—coronary artery disease	9.3e-05	0.000644	CcSEcCtD
Lithium—Vision blurred—Lisinopril—coronary artery disease	9.3e-05	0.000644	CcSEcCtD
Lithium—Gastrointestinal pain—Captopril—coronary artery disease	9.3e-05	0.000644	CcSEcCtD
Lithium—Vomiting—Clopidogrel—coronary artery disease	9.28e-05	0.000642	CcSEcCtD
Lithium—Diarrhoea—Simvastatin—coronary artery disease	9.28e-05	0.000642	CcSEcCtD
Lithium—Arthralgia—Ramipril—coronary artery disease	9.27e-05	0.000641	CcSEcCtD
Lithium—Fatigue—Furosemide—coronary artery disease	9.26e-05	0.000641	CcSEcCtD
Lithium—Tremor—Lisinopril—coronary artery disease	9.25e-05	0.00064	CcSEcCtD
Lithium—Abdominal pain—Telmisartan—coronary artery disease	9.25e-05	0.00064	CcSEcCtD
Lithium—Body temperature increased—Telmisartan—coronary artery disease	9.25e-05	0.00064	CcSEcCtD
Lithium—Vomiting—Lovastatin—coronary artery disease	9.22e-05	0.000638	CcSEcCtD
Lithium—Somnolence—Losartan—coronary artery disease	9.21e-05	0.000637	CcSEcCtD
Lithium—Dizziness—Eplerenone—coronary artery disease	9.2e-05	0.000637	CcSEcCtD
Lithium—Rash—Clopidogrel—coronary artery disease	9.2e-05	0.000637	CcSEcCtD
Lithium—Dermatitis—Clopidogrel—coronary artery disease	9.2e-05	0.000636	CcSEcCtD
Lithium—Asthenia—Valsartan—coronary artery disease	9.19e-05	0.000636	CcSEcCtD
Lithium—Discomfort—Ramipril—coronary artery disease	9.15e-05	0.000634	CcSEcCtD
Lithium—Asthenia—Olmesartan—coronary artery disease	9.15e-05	0.000633	CcSEcCtD
Lithium—Headache—Clopidogrel—coronary artery disease	9.14e-05	0.000633	CcSEcCtD
Lithium—Rash—Lovastatin—coronary artery disease	9.14e-05	0.000633	CcSEcCtD
Lithium—Dermatitis—Lovastatin—coronary artery disease	9.13e-05	0.000632	CcSEcCtD
Lithium—Dyspepsia—Losartan—coronary artery disease	9.12e-05	0.000631	CcSEcCtD
Lithium—Feeling abnormal—Perindopril—coronary artery disease	9.1e-05	0.00063	CcSEcCtD
Lithium—Headache—Lovastatin—coronary artery disease	9.08e-05	0.000629	CcSEcCtD
Lithium—Dry mouth—Ramipril—coronary artery disease	9.06e-05	0.000627	CcSEcCtD
Lithium—Arthralgia—Timolol—coronary artery disease	9.06e-05	0.000627	CcSEcCtD
Lithium—Vomiting—Ezetimibe—coronary artery disease	9.04e-05	0.000626	CcSEcCtD
Lithium—Gastrointestinal pain—Perindopril—coronary artery disease	9.03e-05	0.000625	CcSEcCtD
Lithium—Angioedema—Lisinopril—coronary artery disease	9.02e-05	0.000624	CcSEcCtD
Lithium—Decreased appetite—Losartan—coronary artery disease	9e-05	0.000623	CcSEcCtD
Lithium—Abdominal pain—Captopril—coronary artery disease	8.99e-05	0.000622	CcSEcCtD
Lithium—Body temperature increased—Captopril—coronary artery disease	8.99e-05	0.000622	CcSEcCtD
Lithium—Dizziness—Simvastatin—coronary artery disease	8.97e-05	0.000621	CcSEcCtD
Lithium—Rash—Ezetimibe—coronary artery disease	8.97e-05	0.000621	CcSEcCtD
Lithium—Dermatitis—Ezetimibe—coronary artery disease	8.96e-05	0.00062	CcSEcCtD
Lithium—Confusional state—Ramipril—coronary artery disease	8.96e-05	0.00062	CcSEcCtD
Lithium—Discomfort—Timolol—coronary artery disease	8.95e-05	0.000619	CcSEcCtD
Lithium—Asthenia—Niacin—coronary artery disease	8.94e-05	0.000618	CcSEcCtD
Lithium—Fatigue—Losartan—coronary artery disease	8.93e-05	0.000618	CcSEcCtD
Lithium—Headache—Ezetimibe—coronary artery disease	8.91e-05	0.000617	CcSEcCtD
Lithium—Oedema—Ramipril—coronary artery disease	8.88e-05	0.000615	CcSEcCtD
Lithium—Vertigo—Lisinopril—coronary artery disease	8.87e-05	0.000614	CcSEcCtD
Lithium—Dry mouth—Timolol—coronary artery disease	8.86e-05	0.000613	CcSEcCtD
Lithium—Syncope—Lisinopril—coronary artery disease	8.85e-05	0.000613	CcSEcCtD
Lithium—Vomiting—Eplerenone—coronary artery disease	8.85e-05	0.000613	CcSEcCtD
Lithium—Feeling abnormal—Furosemide—coronary artery disease	8.85e-05	0.000612	CcSEcCtD
Lithium—Nausea—Fenofibrate—coronary artery disease	8.82e-05	0.00061	CcSEcCtD
Lithium—Asthenia—Pravastatin—coronary artery disease	8.8e-05	0.000609	CcSEcCtD
Lithium—Gastrointestinal pain—Furosemide—coronary artery disease	8.78e-05	0.000608	CcSEcCtD
Lithium—Rash—Eplerenone—coronary artery disease	8.78e-05	0.000607	CcSEcCtD
Lithium—Dermatitis—Eplerenone—coronary artery disease	8.77e-05	0.000607	CcSEcCtD
Lithium—Diarrhoea—Valsartan—coronary artery disease	8.76e-05	0.000607	CcSEcCtD
Lithium—Confusional state—Timolol—coronary artery disease	8.76e-05	0.000606	CcSEcCtD
Lithium—Shock—Ramipril—coronary artery disease	8.74e-05	0.000605	CcSEcCtD
Lithium—Abdominal pain—Perindopril—coronary artery disease	8.73e-05	0.000604	CcSEcCtD
Lithium—Body temperature increased—Perindopril—coronary artery disease	8.73e-05	0.000604	CcSEcCtD
Lithium—Diarrhoea—Olmesartan—coronary artery disease	8.72e-05	0.000604	CcSEcCtD
Lithium—Headache—Eplerenone—coronary artery disease	8.72e-05	0.000604	CcSEcCtD
Lithium—Oedema—Timolol—coronary artery disease	8.68e-05	0.000601	CcSEcCtD
Lithium—Loss of consciousness—Lisinopril—coronary artery disease	8.68e-05	0.0006	CcSEcCtD
Lithium—Nausea—Clopidogrel—coronary artery disease	8.67e-05	0.0006	CcSEcCtD
Lithium—Vomiting—Simvastatin—coronary artery disease	8.62e-05	0.000597	CcSEcCtD
Lithium—Nausea—Lovastatin—coronary artery disease	8.61e-05	0.000596	CcSEcCtD
Lithium—Rash—Simvastatin—coronary artery disease	8.55e-05	0.000592	CcSEcCtD
Lithium—Dermatitis—Simvastatin—coronary artery disease	8.54e-05	0.000591	CcSEcCtD
Lithium—Asthenia—Trandolapril—coronary artery disease	8.54e-05	0.000591	CcSEcCtD
Lithium—Shock—Timolol—coronary artery disease	8.54e-05	0.000591	CcSEcCtD
Lithium—Feeling abnormal—Losartan—coronary artery disease	8.54e-05	0.000591	CcSEcCtD
Lithium—Diarrhoea—Niacin—coronary artery disease	8.52e-05	0.00059	CcSEcCtD
Lithium—Asthenia—Enalapril—coronary artery disease	8.51e-05	0.000589	CcSEcCtD
Lithium—Headache—Simvastatin—coronary artery disease	8.5e-05	0.000588	CcSEcCtD
Lithium—Body temperature increased—Furosemide—coronary artery disease	8.49e-05	0.000587	CcSEcCtD
Lithium—Abdominal pain—Furosemide—coronary artery disease	8.49e-05	0.000587	CcSEcCtD
Lithium—Gastrointestinal pain—Losartan—coronary artery disease	8.47e-05	0.000586	CcSEcCtD
Lithium—Dizziness—Valsartan—coronary artery disease	8.47e-05	0.000586	CcSEcCtD
Lithium—Anorexia—Ramipril—coronary artery disease	8.47e-05	0.000586	CcSEcCtD
Lithium—Nausea—Ezetimibe—coronary artery disease	8.45e-05	0.000585	CcSEcCtD
Lithium—Dizziness—Olmesartan—coronary artery disease	8.43e-05	0.000583	CcSEcCtD
Lithium—Arthralgia—Lisinopril—coronary artery disease	8.4e-05	0.000582	CcSEcCtD
Lithium—Asthenia—Telmisartan—coronary artery disease	8.39e-05	0.000581	CcSEcCtD
Lithium—Diarrhoea—Pravastatin—coronary artery disease	8.39e-05	0.000581	CcSEcCtD
Lithium—Discomfort—Lisinopril—coronary artery disease	8.3e-05	0.000575	CcSEcCtD
Lithium—Hypotension—Ramipril—coronary artery disease	8.3e-05	0.000574	CcSEcCtD
Lithium—Anorexia—Timolol—coronary artery disease	8.28e-05	0.000573	CcSEcCtD
Lithium—Nausea—Eplerenone—coronary artery disease	8.27e-05	0.000572	CcSEcCtD
Lithium—Dizziness—Niacin—coronary artery disease	8.24e-05	0.00057	CcSEcCtD
Lithium—Dry mouth—Lisinopril—coronary artery disease	8.22e-05	0.000569	CcSEcCtD
Lithium—Body temperature increased—Losartan—coronary artery disease	8.19e-05	0.000567	CcSEcCtD
Lithium—Abdominal pain—Losartan—coronary artery disease	8.19e-05	0.000567	CcSEcCtD
Lithium—Asthenia—Captopril—coronary artery disease	8.16e-05	0.000565	CcSEcCtD
Lithium—Diarrhoea—Trandolapril—coronary artery disease	8.15e-05	0.000564	CcSEcCtD
Lithium—Vomiting—Valsartan—coronary artery disease	8.14e-05	0.000564	CcSEcCtD
Lithium—Confusional state—Lisinopril—coronary artery disease	8.12e-05	0.000562	CcSEcCtD
Lithium—Diarrhoea—Enalapril—coronary artery disease	8.11e-05	0.000562	CcSEcCtD
Lithium—Hypotension—Timolol—coronary artery disease	8.11e-05	0.000562	CcSEcCtD
Lithium—Dizziness—Pravastatin—coronary artery disease	8.11e-05	0.000561	CcSEcCtD
Lithium—Vomiting—Olmesartan—coronary artery disease	8.1e-05	0.000561	CcSEcCtD
Lithium—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.09e-05	0.00056	CcSEcCtD
Lithium—Rash—Valsartan—coronary artery disease	8.08e-05	0.000559	CcSEcCtD
Lithium—Dermatitis—Valsartan—coronary artery disease	8.07e-05	0.000558	CcSEcCtD
Lithium—Nausea—Simvastatin—coronary artery disease	8.06e-05	0.000558	CcSEcCtD
Lithium—Oedema—Lisinopril—coronary artery disease	8.06e-05	0.000558	CcSEcCtD
Lithium—Rash—Olmesartan—coronary artery disease	8.04e-05	0.000556	CcSEcCtD
Lithium—Dermatitis—Olmesartan—coronary artery disease	8.03e-05	0.000556	CcSEcCtD
Lithium—Headache—Valsartan—coronary artery disease	8.02e-05	0.000555	CcSEcCtD
Lithium—Diarrhoea—Telmisartan—coronary artery disease	8e-05	0.000554	CcSEcCtD
Lithium—Headache—Olmesartan—coronary artery disease	7.99e-05	0.000553	CcSEcCtD
Lithium—Shock—Lisinopril—coronary artery disease	7.93e-05	0.000548	CcSEcCtD
Lithium—Asthenia—Perindopril—coronary artery disease	7.92e-05	0.000548	CcSEcCtD
Lithium—Vomiting—Niacin—coronary artery disease	7.92e-05	0.000548	CcSEcCtD
Lithium—Musculoskeletal discomfort—Timolol—coronary artery disease	7.91e-05	0.000548	CcSEcCtD
Lithium—Somnolence—Ramipril—coronary artery disease	7.9e-05	0.000546	CcSEcCtD
Lithium—Dizziness—Trandolapril—coronary artery disease	7.87e-05	0.000545	CcSEcCtD
Lithium—Rash—Niacin—coronary artery disease	7.85e-05	0.000543	CcSEcCtD
Lithium—Dermatitis—Niacin—coronary artery disease	7.84e-05	0.000543	CcSEcCtD
Lithium—Dizziness—Enalapril—coronary artery disease	7.84e-05	0.000543	CcSEcCtD
Lithium—Dyspepsia—Ramipril—coronary artery disease	7.82e-05	0.000541	CcSEcCtD
Lithium—Headache—Niacin—coronary artery disease	7.8e-05	0.00054	CcSEcCtD
Lithium—Vomiting—Pravastatin—coronary artery disease	7.8e-05	0.00054	CcSEcCtD
Lithium—Diarrhoea—Captopril—coronary artery disease	7.78e-05	0.000539	CcSEcCtD
Lithium—Dizziness—Telmisartan—coronary artery disease	7.74e-05	0.000535	CcSEcCtD
Lithium—Rash—Pravastatin—coronary artery disease	7.73e-05	0.000535	CcSEcCtD
Lithium—Dermatitis—Pravastatin—coronary artery disease	7.72e-05	0.000535	CcSEcCtD
Lithium—Decreased appetite—Ramipril—coronary artery disease	7.72e-05	0.000534	CcSEcCtD
Lithium—Somnolence—Timolol—coronary artery disease	7.72e-05	0.000534	CcSEcCtD
Lithium—Asthenia—Furosemide—coronary artery disease	7.7e-05	0.000533	CcSEcCtD
Lithium—Headache—Pravastatin—coronary artery disease	7.68e-05	0.000532	CcSEcCtD
Lithium—Anorexia—Lisinopril—coronary artery disease	7.68e-05	0.000531	CcSEcCtD
Lithium—Fatigue—Ramipril—coronary artery disease	7.66e-05	0.00053	CcSEcCtD
Lithium—Dyspepsia—Timolol—coronary artery disease	7.64e-05	0.000529	CcSEcCtD
Lithium—Nausea—Valsartan—coronary artery disease	7.61e-05	0.000527	CcSEcCtD
Lithium—Nausea—Olmesartan—coronary artery disease	7.57e-05	0.000524	CcSEcCtD
Lithium—Vomiting—Trandolapril—coronary artery disease	7.57e-05	0.000524	CcSEcCtD
Lithium—Diarrhoea—Perindopril—coronary artery disease	7.56e-05	0.000523	CcSEcCtD
Lithium—Decreased appetite—Timolol—coronary artery disease	7.55e-05	0.000522	CcSEcCtD
Lithium—Vomiting—Enalapril—coronary artery disease	7.54e-05	0.000522	CcSEcCtD
Lithium—Hypotension—Lisinopril—coronary artery disease	7.53e-05	0.000521	CcSEcCtD
Lithium—Dizziness—Captopril—coronary artery disease	7.52e-05	0.000521	CcSEcCtD
Lithium—Rash—Trandolapril—coronary artery disease	7.51e-05	0.00052	CcSEcCtD
Lithium—Dermatitis—Trandolapril—coronary artery disease	7.5e-05	0.000519	CcSEcCtD
Lithium—Fatigue—Timolol—coronary artery disease	7.49e-05	0.000518	CcSEcCtD
Lithium—Rash—Enalapril—coronary artery disease	7.48e-05	0.000518	CcSEcCtD
Lithium—Dermatitis—Enalapril—coronary artery disease	7.47e-05	0.000517	CcSEcCtD
Lithium—Headache—Trandolapril—coronary artery disease	7.46e-05	0.000516	CcSEcCtD
Lithium—Vomiting—Telmisartan—coronary artery disease	7.44e-05	0.000515	CcSEcCtD
Lithium—Asthenia—Losartan—coronary artery disease	7.43e-05	0.000514	CcSEcCtD
Lithium—Headache—Enalapril—coronary artery disease	7.43e-05	0.000514	CcSEcCtD
Lithium—Nausea—Niacin—coronary artery disease	7.4e-05	0.000512	CcSEcCtD
Lithium—Rash—Telmisartan—coronary artery disease	7.38e-05	0.00051	CcSEcCtD
Lithium—Dermatitis—Telmisartan—coronary artery disease	7.37e-05	0.00051	CcSEcCtD
Lithium—Diarrhoea—Furosemide—coronary artery disease	7.35e-05	0.000508	CcSEcCtD
Lithium—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.34e-05	0.000508	CcSEcCtD
Lithium—Headache—Telmisartan—coronary artery disease	7.33e-05	0.000507	CcSEcCtD
Lithium—Feeling abnormal—Ramipril—coronary artery disease	7.32e-05	0.000507	CcSEcCtD
Lithium—Dizziness—Perindopril—coronary artery disease	7.3e-05	0.000505	CcSEcCtD
Lithium—Nausea—Pravastatin—coronary artery disease	7.28e-05	0.000504	CcSEcCtD
Lithium—Gastrointestinal pain—Ramipril—coronary artery disease	7.26e-05	0.000503	CcSEcCtD
Lithium—Vomiting—Captopril—coronary artery disease	7.23e-05	0.000501	CcSEcCtD
Lithium—Rash—Captopril—coronary artery disease	7.17e-05	0.000496	CcSEcCtD
Lithium—Dermatitis—Captopril—coronary artery disease	7.17e-05	0.000496	CcSEcCtD
Lithium—Somnolence—Lisinopril—coronary artery disease	7.16e-05	0.000496	CcSEcCtD
Lithium—Feeling abnormal—Timolol—coronary artery disease	7.16e-05	0.000495	CcSEcCtD
Lithium—Headache—Captopril—coronary artery disease	7.13e-05	0.000493	CcSEcCtD
Lithium—Gastrointestinal pain—Timolol—coronary artery disease	7.1e-05	0.000491	CcSEcCtD
Lithium—Dizziness—Furosemide—coronary artery disease	7.1e-05	0.000491	CcSEcCtD
Lithium—Dyspepsia—Lisinopril—coronary artery disease	7.09e-05	0.000491	CcSEcCtD
Lithium—Diarrhoea—Losartan—coronary artery disease	7.09e-05	0.000491	CcSEcCtD
Lithium—Nausea—Trandolapril—coronary artery disease	7.07e-05	0.00049	CcSEcCtD
Lithium—Nausea—Enalapril—coronary artery disease	7.04e-05	0.000488	CcSEcCtD
Lithium—Vomiting—Perindopril—coronary artery disease	7.02e-05	0.000486	CcSEcCtD
Lithium—Body temperature increased—Ramipril—coronary artery disease	7.02e-05	0.000486	CcSEcCtD
Lithium—Abdominal pain—Ramipril—coronary artery disease	7.02e-05	0.000486	CcSEcCtD
Lithium—Decreased appetite—Lisinopril—coronary artery disease	7e-05	0.000485	CcSEcCtD
Lithium—Rash—Perindopril—coronary artery disease	6.96e-05	0.000482	CcSEcCtD
Lithium—Dermatitis—Perindopril—coronary artery disease	6.96e-05	0.000481	CcSEcCtD
Lithium—Nausea—Telmisartan—coronary artery disease	6.95e-05	0.000481	CcSEcCtD
Lithium—Fatigue—Lisinopril—coronary artery disease	6.94e-05	0.000481	CcSEcCtD
Lithium—Headache—Perindopril—coronary artery disease	6.92e-05	0.000479	CcSEcCtD
Lithium—Body temperature increased—Timolol—coronary artery disease	6.86e-05	0.000475	CcSEcCtD
Lithium—Abdominal pain—Timolol—coronary artery disease	6.86e-05	0.000475	CcSEcCtD
Lithium—Dizziness—Losartan—coronary artery disease	6.85e-05	0.000474	CcSEcCtD
Lithium—Vomiting—Furosemide—coronary artery disease	6.83e-05	0.000472	CcSEcCtD
Lithium—Rash—Furosemide—coronary artery disease	6.77e-05	0.000468	CcSEcCtD
Lithium—Dermatitis—Furosemide—coronary artery disease	6.76e-05	0.000468	CcSEcCtD
Lithium—Nausea—Captopril—coronary artery disease	6.76e-05	0.000468	CcSEcCtD
Lithium—Headache—Furosemide—coronary artery disease	6.73e-05	0.000465	CcSEcCtD
Lithium—Feeling abnormal—Lisinopril—coronary artery disease	6.64e-05	0.000459	CcSEcCtD
Lithium—Gastrointestinal pain—Lisinopril—coronary artery disease	6.59e-05	0.000456	CcSEcCtD
Lithium—Vomiting—Losartan—coronary artery disease	6.59e-05	0.000456	CcSEcCtD
Lithium—Nausea—Perindopril—coronary artery disease	6.56e-05	0.000454	CcSEcCtD
Lithium—Rash—Losartan—coronary artery disease	6.53e-05	0.000452	CcSEcCtD
Lithium—Dermatitis—Losartan—coronary artery disease	6.53e-05	0.000452	CcSEcCtD
Lithium—Headache—Losartan—coronary artery disease	6.49e-05	0.000449	CcSEcCtD
Lithium—Nausea—Furosemide—coronary artery disease	6.38e-05	0.000441	CcSEcCtD
Lithium—Asthenia—Ramipril—coronary artery disease	6.37e-05	0.000441	CcSEcCtD
Lithium—Body temperature increased—Lisinopril—coronary artery disease	6.37e-05	0.000441	CcSEcCtD
Lithium—Abdominal pain—Lisinopril—coronary artery disease	6.37e-05	0.000441	CcSEcCtD
Lithium—Asthenia—Timolol—coronary artery disease	6.23e-05	0.000431	CcSEcCtD
Lithium—Nausea—Losartan—coronary artery disease	6.15e-05	0.000426	CcSEcCtD
Lithium—Diarrhoea—Ramipril—coronary artery disease	6.08e-05	0.000421	CcSEcCtD
Lithium—Diarrhoea—Timolol—coronary artery disease	5.94e-05	0.000411	CcSEcCtD
Lithium—Dizziness—Ramipril—coronary artery disease	5.87e-05	0.000407	CcSEcCtD
Lithium—Asthenia—Lisinopril—coronary artery disease	5.78e-05	0.0004	CcSEcCtD
Lithium—Dizziness—Timolol—coronary artery disease	5.74e-05	0.000397	CcSEcCtD
Lithium—Vomiting—Ramipril—coronary artery disease	5.65e-05	0.000391	CcSEcCtD
Lithium—Rash—Ramipril—coronary artery disease	5.6e-05	0.000388	CcSEcCtD
Lithium—Dermatitis—Ramipril—coronary artery disease	5.6e-05	0.000387	CcSEcCtD
Lithium—Headache—Ramipril—coronary artery disease	5.56e-05	0.000385	CcSEcCtD
Lithium—Vomiting—Timolol—coronary artery disease	5.52e-05	0.000382	CcSEcCtD
Lithium—Diarrhoea—Lisinopril—coronary artery disease	5.51e-05	0.000381	CcSEcCtD
Lithium—Rash—Timolol—coronary artery disease	5.47e-05	0.000379	CcSEcCtD
Lithium—Dermatitis—Timolol—coronary artery disease	5.47e-05	0.000379	CcSEcCtD
Lithium—Headache—Timolol—coronary artery disease	5.44e-05	0.000376	CcSEcCtD
Lithium—Dizziness—Lisinopril—coronary artery disease	5.33e-05	0.000369	CcSEcCtD
Lithium—Nausea—Ramipril—coronary artery disease	5.28e-05	0.000365	CcSEcCtD
Lithium—Nausea—Timolol—coronary artery disease	5.16e-05	0.000357	CcSEcCtD
Lithium—Vomiting—Lisinopril—coronary artery disease	5.12e-05	0.000354	CcSEcCtD
Lithium—Rash—Lisinopril—coronary artery disease	5.08e-05	0.000352	CcSEcCtD
Lithium—Dermatitis—Lisinopril—coronary artery disease	5.07e-05	0.000351	CcSEcCtD
Lithium—Headache—Lisinopril—coronary artery disease	5.05e-05	0.000349	CcSEcCtD
Lithium—Nausea—Lisinopril—coronary artery disease	4.78e-05	0.000331	CcSEcCtD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—AKT1—coronary artery disease	1.14e-05	6.57e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL10—coronary artery disease	1.13e-05	6.54e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—BCL2—coronary artery disease	1.13e-05	6.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PLG—coronary artery disease	1.13e-05	6.52e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—APOA1—coronary artery disease	1.13e-05	6.51e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1A—coronary artery disease	1.12e-05	6.44e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—KIT—coronary artery disease	1.12e-05	6.44e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—KITLG—coronary artery disease	1.12e-05	6.44e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFBR2—coronary artery disease	1.12e-05	6.44e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL18—coronary artery disease	1.12e-05	6.43e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL3—coronary artery disease	1.12e-05	6.43e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL2—coronary artery disease	1.12e-05	6.43e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD40LG—coronary artery disease	1.11e-05	6.41e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—HGF—coronary artery disease	1.11e-05	6.41e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SDC1—coronary artery disease	1.1e-05	6.36e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—F2R—coronary artery disease	1.1e-05	6.36e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRB2—coronary artery disease	1.1e-05	6.35e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CSF2—coronary artery disease	1.1e-05	6.34e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF1—coronary artery disease	1.1e-05	6.34e-05	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—coronary artery disease	1.1e-05	6.32e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—STAT5A—coronary artery disease	1.09e-05	6.29e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCE—coronary artery disease	1.09e-05	6.27e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SOCS1—coronary artery disease	1.08e-05	6.25e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—S100B—coronary artery disease	1.08e-05	6.23e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MEF2C—coronary artery disease	1.08e-05	6.23e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGB—coronary artery disease	1.08e-05	6.22e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6ST—coronary artery disease	1.07e-05	6.19e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—GSK3B—coronary artery disease	1.07e-05	6.18e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AGER—coronary artery disease	1.07e-05	6.18e-05	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PIK3CA—coronary artery disease	1.07e-05	6.18e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SOCS3—coronary artery disease	1.07e-05	6.17e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP9—coronary artery disease	1.07e-05	6.16e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EDNRB—coronary artery disease	1.07e-05	6.16e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS2—coronary artery disease	1.07e-05	6.14e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—CREB1—coronary artery disease	1.06e-05	6.13e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—AKT1—coronary artery disease	1.06e-05	6.11e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFBR2—coronary artery disease	1.06e-05	6.1e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KITLG—coronary artery disease	1.06e-05	6.1e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOB—coronary artery disease	1.06e-05	6.08e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—THBS1—coronary artery disease	1.05e-05	6.06e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PSMB5—coronary artery disease	1.04e-05	6e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PSMA6—coronary artery disease	1.04e-05	6e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6R—coronary artery disease	1.04e-05	5.98e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD36—coronary artery disease	1.04e-05	5.98e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP3—coronary artery disease	1.03e-05	5.96e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT5A—coronary artery disease	1.03e-05	5.96e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK1—coronary artery disease	1.03e-05	5.95e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—KIT—coronary artery disease	1.03e-05	5.94e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—coronary artery disease	1.03e-05	5.92e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PPP2CA—coronary artery disease	1.02e-05	5.9e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF1—coronary artery disease	1.02e-05	5.85e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EDNRA—coronary artery disease	1.01e-05	5.81e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—LPL—coronary artery disease	1.01e-05	5.81e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKCD—coronary artery disease	1.01e-05	5.79e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CYBA—coronary artery disease	1e-05	5.79e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB1—coronary artery disease	1e-05	5.79e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOB—coronary artery disease	1e-05	5.76e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DUSP6—coronary artery disease	1e-05	5.76e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—GSK3B—coronary artery disease	9.9e-06	5.7e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EDN1—coronary artery disease	9.84e-06	5.67e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLAT—coronary artery disease	9.83e-06	5.67e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—C3—coronary artery disease	9.83e-06	5.66e-05	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AKT1—coronary artery disease	9.82e-06	5.66e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—CREB1—coronary artery disease	9.82e-06	5.66e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL5—coronary artery disease	9.77e-06	5.63e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF1—coronary artery disease	9.62e-06	5.54e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CSF2—coronary artery disease	9.62e-06	5.54e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—VEGFA—coronary artery disease	9.6e-06	5.53e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6R—coronary artery disease	9.58e-06	5.52e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LPL—coronary artery disease	9.55e-06	5.5e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL12—coronary artery disease	9.49e-06	5.47e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—BDKRB2—coronary artery disease	9.49e-06	5.47e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT1—coronary artery disease	9.48e-06	5.46e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MEF2C—coronary artery disease	9.46e-06	5.45e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RPS6KB1—coronary artery disease	9.46e-06	5.45e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PPP2CA—coronary artery disease	9.45e-06	5.45e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2L1—coronary artery disease	9.41e-06	5.42e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF2—coronary artery disease	9.4e-06	5.42e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—coronary artery disease	9.35e-06	5.39e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—JUNB—coronary artery disease	9.31e-06	5.36e-05	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—coronary artery disease	9.3e-06	5.36e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PRKCD—coronary artery disease	9.28e-06	5.35e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLCB1—coronary artery disease	9.28e-06	5.35e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ITGB3—coronary artery disease	9.22e-06	5.31e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR7—coronary artery disease	9.08e-06	5.23e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—coronary artery disease	9.07e-06	5.23e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—JAK2—coronary artery disease	9.01e-06	5.19e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—SERPINE1—coronary artery disease	8.97e-06	5.17e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PIK3CA—coronary artery disease	8.96e-06	5.16e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PPP2CA—coronary artery disease	8.96e-06	5.16e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—BCL2—coronary artery disease	8.93e-06	5.15e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK14—coronary artery disease	8.9e-06	5.13e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—coronary artery disease	8.81e-06	5.08e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCD—coronary artery disease	8.8e-06	5.07e-05	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AKT1—coronary artery disease	8.76e-06	5.05e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT1—coronary artery disease	8.73e-06	5.03e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF2—coronary artery disease	8.68e-06	5e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ITGAV—coronary artery disease	8.66e-06	4.99e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—HIF1A—coronary artery disease	8.65e-06	4.99e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MAPK1—coronary artery disease	8.64e-06	4.98e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KNG1—coronary artery disease	8.63e-06	4.97e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—coronary artery disease	8.61e-06	4.96e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PIK3CA—coronary artery disease	8.6e-06	4.96e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—C3—coronary artery disease	8.6e-06	4.95e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6ST—coronary artery disease	8.59e-06	4.95e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—ICAM1—coronary artery disease	8.59e-06	4.95e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGTR1—coronary artery disease	8.58e-06	4.94e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—coronary artery disease	8.56e-06	4.93e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—NFKBIA—coronary artery disease	8.53e-06	4.91e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—coronary artery disease	8.45e-06	4.87e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL10—coronary artery disease	8.38e-06	4.83e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLG—coronary artery disease	8.36e-06	4.82e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOA1—coronary artery disease	8.35e-06	4.81e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—JAK2—coronary artery disease	8.32e-06	4.8e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—KIT—coronary artery disease	8.26e-06	4.76e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—coronary artery disease	8.23e-06	4.74e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HIF1A—coronary artery disease	8.2e-06	4.72e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AGT—coronary artery disease	8.17e-06	4.71e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB2—coronary artery disease	8.14e-06	4.69e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCE—coronary artery disease	8.04e-06	4.63e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SOCS1—coronary artery disease	8.02e-06	4.62e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—coronary artery disease	8e-06	4.61e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—coronary artery disease	8e-06	4.61e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—S100B—coronary artery disease	8e-06	4.61e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—coronary artery disease	7.93e-06	4.57e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6ST—coronary artery disease	7.93e-06	4.57e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SOCS3—coronary artery disease	7.92e-06	4.56e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOA1—coronary artery disease	7.91e-06	4.56e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—coronary artery disease	7.89e-06	4.55e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS2—coronary artery disease	7.87e-06	4.54e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CREB1—coronary artery disease	7.86e-06	4.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KDR—coronary artery disease	7.84e-06	4.52e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—coronary artery disease	7.83e-06	4.51e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFBR2—coronary artery disease	7.82e-06	4.51e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KITLG—coronary artery disease	7.82e-06	4.51e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK14—coronary artery disease	7.79e-06	4.49e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6R—coronary artery disease	7.67e-06	4.42e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT5A—coronary artery disease	7.65e-06	4.41e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP3—coronary artery disease	7.65e-06	4.41e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ESR1—coronary artery disease	7.64e-06	4.4e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK1—coronary artery disease	7.63e-06	4.4e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—KIT—coronary artery disease	7.62e-06	4.39e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—F2—coronary artery disease	7.55e-06	4.35e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FN1—coronary artery disease	7.55e-06	4.35e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6ST—coronary artery disease	7.52e-06	4.33e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NFKBIA—coronary artery disease	7.46e-06	4.3e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOB—coronary artery disease	7.39e-06	4.26e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT1—coronary artery disease	7.32e-06	4.22e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EDN1—coronary artery disease	7.27e-06	4.19e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CREB1—coronary artery disease	7.26e-06	4.18e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KIT—coronary artery disease	7.22e-06	4.16e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL5—coronary artery disease	7.22e-06	4.16e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CSF2—coronary artery disease	7.11e-06	4.1e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF1—coronary artery disease	7.11e-06	4.1e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6R—coronary artery disease	7.08e-06	4.08e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LPL—coronary artery disease	7.06e-06	4.07e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT1—coronary artery disease	7.03e-06	4.05e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MEF2C—coronary artery disease	6.99e-06	4.03e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RPS6KB1—coronary artery disease	6.99e-06	4.03e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF2—coronary artery disease	6.95e-06	4e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GSK3B—coronary artery disease	6.93e-06	3.99e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—coronary artery disease	6.88e-06	3.96e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CREB1—coronary artery disease	6.88e-06	3.96e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ITGB3—coronary artery disease	6.82e-06	3.93e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL2—coronary artery disease	6.73e-06	3.88e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6R—coronary artery disease	6.71e-06	3.86e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—JAK2—coronary artery disease	6.66e-06	3.84e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—coronary artery disease	6.64e-06	3.83e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—SERPINE1—coronary artery disease	6.63e-06	3.82e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PIK3CA—coronary artery disease	6.62e-06	3.82e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PPP2CA—coronary artery disease	6.62e-06	3.81e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—coronary artery disease	6.61e-06	3.81e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2—coronary artery disease	6.6e-06	3.8e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCD—coronary artery disease	6.5e-06	3.75e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF2—coronary artery disease	6.42e-06	3.7e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—coronary artery disease	6.36e-06	3.67e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PIK3CA—coronary artery disease	6.36e-06	3.66e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—C3—coronary artery disease	6.35e-06	3.66e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—coronary artery disease	6.33e-06	3.65e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SERPINE1—coronary artery disease	6.28e-06	3.62e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—JAK2—coronary artery disease	6.15e-06	3.54e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT1—coronary artery disease	6.12e-06	3.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF2—coronary artery disease	6.08e-06	3.5e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HIF1A—coronary artery disease	6.06e-06	3.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGT—coronary artery disease	6.04e-06	3.48e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK1—coronary artery disease	6.01e-06	3.47e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—coronary artery disease	6e-06	3.46e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—coronary artery disease	5.91e-06	3.41e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—coronary artery disease	5.91e-06	3.41e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—coronary artery disease	5.86e-06	3.38e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOA1—coronary artery disease	5.85e-06	3.37e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—coronary artery disease	5.83e-06	3.36e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—JAK2—coronary artery disease	5.83e-06	3.36e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KDR—coronary artery disease	5.79e-06	3.34e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—coronary artery disease	5.79e-06	3.33e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK14—coronary artery disease	5.76e-06	3.32e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—coronary artery disease	5.66e-06	3.26e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ESR1—coronary artery disease	5.65e-06	3.25e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—F2—coronary artery disease	5.58e-06	3.21e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FN1—coronary artery disease	5.58e-06	3.21e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6ST—coronary artery disease	5.56e-06	3.2e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MAPK1—coronary artery disease	5.55e-06	3.2e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NFKBIA—coronary artery disease	5.51e-06	3.18e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT1—coronary artery disease	5.41e-06	3.12e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KIT—coronary artery disease	5.34e-06	3.08e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL8—coronary artery disease	5.32e-06	3.06e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3CA—coronary artery disease	5.22e-06	3.01e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT1—coronary artery disease	5.19e-06	2.99e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CASP3—coronary artery disease	5.09e-06	2.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—coronary artery disease	5.08e-06	2.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CREB1—coronary artery disease	5.08e-06	2.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL2—coronary artery disease	4.97e-06	2.86e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6R—coronary artery disease	4.96e-06	2.86e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCND1—coronary artery disease	4.96e-06	2.86e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—coronary artery disease	4.89e-06	2.82e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3CA—coronary artery disease	4.82e-06	2.78e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP9—coronary artery disease	4.81e-06	2.77e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SERPINE1—coronary artery disease	4.64e-06	2.67e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—coronary artery disease	4.62e-06	2.66e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF2—coronary artery disease	4.49e-06	2.59e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK1—coronary artery disease	4.44e-06	2.56e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—coronary artery disease	4.43e-06	2.55e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VEGFA—coronary artery disease	4.32e-06	2.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—JAK2—coronary artery disease	4.31e-06	2.48e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—coronary artery disease	4.27e-06	2.46e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT1—coronary artery disease	4.26e-06	2.46e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—coronary artery disease	4.18e-06	2.41e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MAPK1—coronary artery disease	4.1e-06	2.36e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—coronary artery disease	3.97e-06	2.28e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT1—coronary artery disease	3.94e-06	2.27e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL8—coronary artery disease	3.93e-06	2.26e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK1—coronary artery disease	3.89e-06	2.24e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3CA—coronary artery disease	3.86e-06	2.22e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CASP3—coronary artery disease	3.76e-06	2.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCND1—coronary artery disease	3.66e-06	2.11e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3CA—coronary artery disease	3.56e-06	2.05e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP9—coronary artery disease	3.56e-06	2.05e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—coronary artery disease	3.42e-06	1.97e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CA—coronary artery disease	3.37e-06	1.94e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VEGFA—coronary artery disease	3.19e-06	1.84e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—coronary artery disease	3.15e-06	1.82e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT1—coronary artery disease	3.15e-06	1.82e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—coronary artery disease	2.99e-06	1.72e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—coronary artery disease	2.93e-06	1.69e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT1—coronary artery disease	2.91e-06	1.68e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK1—coronary artery disease	2.87e-06	1.66e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT1—coronary artery disease	2.76e-06	1.59e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CA—coronary artery disease	2.49e-06	1.44e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—coronary artery disease	2.21e-06	1.27e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT1—coronary artery disease	2.04e-06	1.17e-05	CbGpPWpGaD
